Picture of Bioscience Neutraceuticals logo

DEVV Bioscience Neutraceuticals Income Statement

0.000.00%
us flag iconLast trade - 00:00
IndustrialsHighly SpeculativeMicro Cap

Annual income statement for Bioscience Neutraceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2015
December 31st
R2016
December 31st
R2017
December 31st
2018
December 31st
2019
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue00000
Cost of Revenue
Gross Profit0
Selling / General / Administrative Expenses
Unusual Expense / Income
Total Operating Expenses0.0480.0110.0230.0360.46
Operating Profit-0.048-0.011-0.023-0.036-0.46
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes-0.048-0.011-0.051-0.061-0.626
Provision for Income Taxes
Net Income After Taxes-0.048-0.011-0.051-0.061-0.626
Net Income Before Extraordinary Items
Extraordinary Items
Net Income-0.048-0.011-0.15-0.074-0.626
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-0.048-0.011-0.15-0.074-0.626
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.202-0.045-0.215-0.253-0.098

Or unlock with your email

Or unlock with your email